At the NCCN Annual Conference, Dr. Bijal Shah of Tampa’s Moffitt Cancer Center highlighted ongoing challenges in administration of CAR T-cell therapy.
Original Article: CAR T-Cell Therapy in ALL: Formidible Challenges Remain